39 results
8-K
EX-99.1
BTAX
Biostax Corp.
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
Union and foreign countries; the performance of each company’s third-party suppliers and manufacturers; the success of competing therapies
8-K
EX-99.1
BTAX
Biostax Corp.
16 Apr 20
Immune Therapeutics, Inc. and Forte Biotechnology Intl Corp Sign Sub-Licensing Agreement for Animal Health Applications
4:12pm
States (US) and the European Union (EU). In addition, Forte agreed to pay Immune single-digit royalty payments based on future net sales of Lodonal™
S-1
u8pp6k7h iajv9dy
14 Oct 16
IPO registration
12:00am
DRS/A
b4w2d2mbr3elw45fuy
14 Oct 16
Draft registration statement (amended)
12:00am
8-K
EX-10.1
8uaue0 ke0kh0a8icve0
20 May 16
Other Events
12:00am